Drug recall · May 4, 2022
Losartan Potassium Tab. USP 50mg recall
Why: CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Losartan Potassium Tab. USP 50mg, Pkg Size: 30, Mfg: Lupin Pharmaceuticals, Inc., Preferred Pharmaceuticals, Inc.
- Lots / codes
Lot: E1321O, Exp.: 5/31/2023 Lot: E2521H, Exp.: 5/31/2023 Lot: E2621F, Exp.: 5/31/2023
- Quantity
- 44 Bottles of 90 Tablets 33 Bottles of 30 Tablets
- Company
- Preferred Pharmaceuticals, Inc., Anaheim, CA
- Distribution
- Nationwide within the U.S to CA, IN and FL.
- Initiated
- April 12, 2022 · Voluntary: Firm initiated
- Classified
- April 26, 2022
- Reported
- May 4, 2022
- Ended
- September 22, 2022
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Losartan
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.